North Carolina ’s First Double Hand Transplant Recipient Grateful for Gift

Treatment TermsHand transplantTransplant program Author Morgan deBlecourt Overview In April 2017, Debra Kelly developed an invasive strep A infection that almost killed her and required her hands and legs to be amputated. Just 10 months after learning about Duke ’s hand transplant program, Kelly became the first person in North Carolina to receive a bilateral hand transplant. Today she is thrilled to be regaining her independence and returning to the activities she loves. Preview Image Content Blocks Patient Photo Gender Female Featured Doctors Linda Carime Cendales, MD Related Blog Posts First Hand Transplant Recipient in NC Gains Use of New Hand (Video) Hand transplant now an option for limb loss First Hand Transplant in North Carolina Surgery, OT Restores Hand Function After Devastating Injury (Video) BodyDisplay in Announcement Section:  ArchivedThumbnail Image: Pin to Top of WiFi Page: 
Source: Duke Health News - Category: Consumer Health News Authors: Source Type: news

Related Links:

Publication date: Available online 10 July 2020Source: American Journal of Kidney DiseasesAuthor(s): Lara Meyer, Marc Ulrich, Didier Ducloux, Valérie Garrigue, Cécile Vigneau, Dominique Nochy, Guillaume Bobrie, Sophie Ferlicot, Magalie Colombat, Jean-Jacques Boffa, Karine Clabault, Jeannette Mansour, Christiane Mousson, Raymond Azar, Jean-Louis Bacri, Antoine Dürrbach, Christian Duvic, Khalil El Karoui, Maxime Hoffmann, Arnaud Lionet
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
Conclusions: HRU and costs from HCT to PTLD were high and more than doubled within 1-year post-PTLD. PTLD patients who died had ∼7 times higher costs than those who lived, driven by hospitalizations. Effective treatments are needed to reduce the burden of PTLD. PMID: 32643493 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
Publication date: Available online 11 July 2020Source: Medical Journal Armed Forces IndiaAuthor(s): Nikita Naredi, Pankaj Talwar, Sandeep Karunakaran
Source: Medical Journal Armed Forces India - Category: General Medicine Source Type: research
Publication date: Available online 10 July 2020Source: Hepatobiliary &Pancreatic Diseases InternationalAuthor(s): Deniz Balci, Elvan Onur Kirimker
Source: Hepatobiliary and Pancreatic Diseases International - Category: Gastroenterology Source Type: research
Publication date: Available online 11 July 2020Source: The Annals of Thoracic SurgeryAuthor(s): Ian G. Christie, Ernest G. Chan, John P. Ryan, Takashi Harano, Matthew Morrell, James D. Luketich, Pablo G. Sanchez
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Conclusion: MKTP is a safe and effective method for treating refractory vitiligo and nevus depigmentosus in Thai patients. PMID: 32643482 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
Authors: Kobayashi H, Asada N, Igawa T, Abe M, Meguri Y, Ennishi D, Nishimori H, Fujii N, Matsuoka KI, Yoshino T, Maeda Y Abstract Breast involvement of Adult T-cell leukemia-lymphoma (ATLL) is extremely rare, and the data on the characteristics are limited. We herein describe a 49-year-old woman who presented with skin involvement of ATLL. Positron emission tomography/computed tomography showed bilateral breast lesions. Although the patient once achieved a complete metabolic response, a relapse of her ATLL occurred. The patient received subsequent allogeneic hematopoietic stem cell transplantation (HSCT). To our k...
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
We present the case of a 53-year-old woman with prefibrotic stage primary myelofibrosis who underwent cord blood transplantation. Nine years after transplantation, she relapsed, which was confirmed by a bone marrow examination. We decided to treat her using azacitidine. After three courses of azacitidine, a partial cytogenetic response was confirmed. Azacitidine maintenance therapy successfully maintained a low level of recipient-origin peripheral blood cells with a stable hematological condition. Azacitidine may therefore be a promising therapeutic option for primary myelofibrosis patients who relapse after allogeneic ste...
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
To identify predictors of portal hypertension, liver transplantation, and death in North American youth with alpha-1-antitrypsin (AAT) deficiency, and compare with AAT deficiency patients elsewhere.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Original Articles Source Type: research
We thank Dr. Imamura for his interest in our study, which suggests that long-term milrinone therapy is effective and safe, in select patients, as a bridge to heart transplantation [1]. We agree with Dr. Imamura that clinician bias may limit this real-world analysis. However, in our analysis we found that failure patients demonstrated hemodynamic deterioration with worsening (increasing) pulmonary artery pressure from baseline to the study endpoint. This data is displayed in Figure 1 of the article and provides objective evidence of the failure patients' need for mechanical support.
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Letter to the Editor Source Type: research
More News: Blogging | Health | Learning | Transplant Surgery | Transplants | Universities & Medical Training